Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 6
Submit an article Journal homepage
407
Views
16
CrossRef citations to date
0
Altmetric
Letter to the Editor

Retinal Vasculitis Associated with Ipilimumab

Edmund Tsui1 F.I. Proctor Foundation, University of California, San Francisco, California, USA;2 Department of Ophthalmology, University of California, San Francisco, California, USAORCID Iconhttps://orcid.org/0000-0001-7532-9191
ORCID Icon &
John A. Gonzales1 F.I. Proctor Foundation, University of California, San Francisco, California, USA;2 Department of Ophthalmology, University of California, San Francisco, California, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0558-9793
ORCID Icon
Pages 868-870 | Received 27 Jan 2019, Accepted 18 Apr 2019, Published online: 17 Jul 2019

References

  • Postow MA, Sidlow R, Hellmann MD. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018;378(2):158–168. doi:10.1056/NEJMc1711583.
  • Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: american Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714–1768. doi:10.1200/JCO.2017.77.6385.
  • Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: systemic Indications and Ophthalmic Side Effects. Retina (Philadelphia, Pa). 2018;38(6):1063–1078. doi:10.1097/IAE.0000000000002181.
  • Wong RK, Lee JK, Huang JJ. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome. Retin Cases Brief Rep. 2012;6(4):423–426. doi:10.1097/ICB.0b013e31824f7130.
  • Laovirojjanakul W, Acharya N, Gonzales JA. Ultra-Widefield Fluorescein Angiography in Intermediate Uveitis. Ocul Immunol Inflamm. October 2017:1–6.
  • Fierz FC, Meier F, Chaloupka K, Böni C. Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review. Klin Monbl Augenheilkd. 2016;233(4):540–544. doi:10.1055/s-0042-102668.
  • Manusow JS, Khoja L, Pesin N, Joshua AM, Mandelcorn ED. Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma. J Immunother Cancer. 2014;2(1):41. doi:10.1186/s40425-014-0041-1.
  • Aaberg MT, Aaberg TM. PEMBROLIZUMAB ADMINISTRATION ASSOCIATED WITH POSTERIOR UVEITIS. Retin Cases Brief Rep. 2017;11:348–351.
  • Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review. JAMA Oncol. 2016;2(10):1346–1353. doi:10.1001/jamaoncol.2015.5778.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.